Target intelligence / Profile preview

Guanylate cyclase 1 soluble subunit beta-1 (GUCY1B1)

Target
GUCY1B1
Molecular classification
Enzyme (specifically, soluble guanylate cyclase subunit), Nitric oxide sensor protein
01

Overview

Guanylate cyclase 1 soluble subunit beta-1 is a catalytic subunit of soluble guanylate cyclase (sGC), an enzyme critical for nitric oxide (NO) signaling in human physiology. It forms a heterodimer with the alpha subunit (typically sGCα1), and together this enzyme acts as the primary cellular receptor for nitric oxide. Upon binding NO, the heme-containing domain in the beta-1 subunit facilitates a conformational change, dramatically increasing sGC's catalytic efficiency to convert GTP to cGMP, a second messenger that mediates smooth muscle relaxation, vasodilation, neurotransmission, and inhibition of platelet aggregation. Dysregulation or dysfunction of this enzyme system is relevant to cardiovascular, neurodegenerative, and proliferative diseases. It is a validated drug target for approved vasodilators and sGC stimulators.

Other names
Gc70GCbeta1GC-SB3GC-S-beta-1GC-S-β-1GCYB1guanylate cyclase 1, soluble, beta 1guanylate cyclase 1 soluble subunit β 1guanylate cyclase 1, soluble, β 1GUC1B3GUCB3GUCSB3GUCY1B3NO-GC beta 1Nogc beta1 subunitNO-GC β 1NO receptor guanylyl cyclase beta1 subunitSGCSgc beta-1SGC-β-1
02

Mechanism of action

Drugs stimulate guanylate cyclase activity, increasing cGMP production by mimicking or enhancing the action of nitric oxide or directly activating the enzyme

03

Biological functions

Signal transductionCatalysis of cyclic guanosine monophosphate (cGMP) synthesisMediation of nitric oxide signaling pathways
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseOther (e.g., smooth muscle relaxation disorders, some cancers)
05

Safety considerations

Excessive activation can cause hypotensionPotential rebound hypertension if discontinued suddenlyDrug interactions with phosphodiesterase inhibitors (risk of dangerously low blood pressure)
06

Interacting drugs

Nitroglycerin (and other nitrovasodilators)

3 more in the full profile.

07

Biomarkers

cGMP levels (as a downstream functional indicator)

Beyond the preview

Go deeper on Guanylate cyclase 1 soluble subunit beta-1 (GUCY1B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate cyclase 1 soluble subunit beta-1 (GUCY1B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call